Monsenso (MONSO) Stock Overview

Monsenso A/S develops and sells digital health solution for the treatment of mental disorders. It offers Monsenso app for individuals that help them in the areas of self-assessments and questionnaires, sensor data collection from phones and wearables, reminders on medication and sessions, visualizations and motivational feedback, and psychoeducation and cognitive behavioral therapy; and app for carers that help them in the areas of self-assessments, questionnaires, psychoeducation, and a range of learning tools. The company also provides clinical web portal for clinicians enable users for the visualization of patient data, patient dashboard, historical overview, correlation analysis, messaging, shared decision-making, and notes/medical record keeping; and data analytics for clinicians for historical aggregation of health and behavioral data, statistical descriptors, correlation between behavioral data and illness progression, pattern analysis, predictive analytics and mood forecasting, and risk assessment. It serves patients, clinicians, healthcare systems and researchers, and carers. Monsenso A/S was incorporated in 2013 and is based in Copenhagen, Denmark.